Lumox

🌟 Baby News from Lumox! 🌟 Our co-founder Irati is heading off on a new adventure: maternity leave! While she and her partner will be busy with a new baby and an energetic 2-year-old, Sebas will be here taking care of her other “baby”—Lumox! He’ll be hitting the road, pitching to share our story—first stop: the Healthy Ideas, Healthy Returns (HIHR) conference and the Dutch Life Sciences conference. If you’re there, come say hi and learn about our true targeted therapy using harmless light! And if you see him juggling too many things, maybe just wish him luck. 😉 Here’s to an exciting few months! 💫 #TeamLumox #StartupLife #TrueTargetedTherapy #HIHR #DutchLifeScience

IRATI AND SEBAS ARE GETTING TRAINED... AND PAID! 🚀💡 Every year, 14 scientists are handpicked to turn their research into real-world impact. These lucky few get monthly 3-day training sessions and the chance to focus on one thing: making their start-up a success. This is what the Faculty of Impact is all about. 🎉 Both Irati and Sebas Pronk have been accepted into this prestigious program! That means we’re sharpening our skills, building our network, and can fully focus on making Lumox a game-changer in cancer treatment. With the support of Faculty of Impact, we’re on a mission to selectively kill cancer with light, and bring a powerful precision therapy to patients!

“The pathway of transforming research into a start-up is not obvious” Irati explained in her interview with UtrechtInc. Are you curious about Irati‘s thoughts regarding bringing academic research into a start-up, and how a start-up incubator like UtrechtInc can help? Read the interview via https://lnkd.in/eY7tDcdx

🚀 One Week Left to Apply for the Venture Challenge! 🚀 📅 Deadline: 2 July 2024, 14:00 hrs 📅 We’re excited to share a special message from Venture Challenge Alumnus Irati Beltrán Hernández, founder of Lumox, who highlights the value the Venture Challenge brings. Watch the video to learn why this opportunity could be a game-changer for your innovation! 🌟 🔗 https://lnkd.in/e-VGngP #VentureChallenge #Entrepreneurship #Startups #Innovation #ApplyNow #DeadlineApproaching

Last week we hosted our exciting Big Event! This annual event consists of an introduction to new HPPS students, an Update part, a Thematic part and finally a fun pubquiz to finish it off. After Selma Batur’s introduction, HPPS Coordinator Freija ter Heegde did a presentation about educational philosophy and the different goals of teaching. For the Update part, three HPPS members presented. Collin Schouten did a presentation about a book he read called “Thinking fast and slow” by Daniel Kahneman. Ines E. presented about the documentary project. Eirini (Irene) Malamou did her presentation about the mental health Instagram project. For the Thematic part we had two amazing speakers that presented. Sebas Pronk from Lumox presented about a possible revolutionary way to cure cancer using nanobodies and light. Finally, Ed Moret presented about AI. Thank you to all the speakers who took the time out of their day to join us!

We are proud to announce our collaboration with Lumox. NovoSere will act as plug-in CMC team to define the CMC roadmap towards first in human studies and to select fit for purpose & cost-effective CDMOs to enable manufacturing of the nanobody-drug conjugates. Lumox is developing a unique technology that allows them to kill cancer cells without affecting healthy cells. They treat cancer with minimal side effects, combining nanobodies and light. The technology has undergone extensive validation in preclinical models. NovoSere is ready to make Lumox’ journey towards clinical Proof of Concept a success! #CMC #biologics #nanobody #oncology #targeting

Yesterday, UtrechtInc, in collaboration with Business for Life, hosted an open event to explore science and entrepreneurship! 🎉 It was a great success, and we thank everyone who joined! First, our student startup scout, Jelmer van der Velde, introduced the audience to UtrechtInc. Then, Sebas Pronk and Irati Beltrán Hernández from Lumox took the stage and shared their journey towards entrepreneurship, which wasn't straightforward, as both come from academia. Irati explained the science behind their light-activated drug for treating cancer, which is incredibly cool! The audience was captivated by this groundbreaking treatment and participated enthusiastically. 🙌 Thank you, Sebas and Irati, for being so earnest, and thanks to the audience for asking such intriguing questions. The topic of patenting a life science innovation was particularly clarified for many attendees. 💡 Lumox is a promising startup that has recently secured multiple subsidies, facilitating the steps to bring their innovation to market. Good luck with everything that comes your way, Sebas and Irati! 🌟 Stay up to date on Lumox's latest developments by following their LinkedIn page or checking out their website: https://lnkd.in/eVu6aJM5. #BusinessForLife #Lumox #CancerTreatment #NetworkingEvent #Entrepreneurship #Innovation #UtrechtInc

Congratulations to Lumox! They have been awarded one of the innovation vouchers worth €40,000 from Utrecht Holdings. Each year, Utrecht Holdings empowers groundbreaking research and drives its advancement and valorization impact by awarding innovation vouchers.

We won €40.000!! The Lumox team was awarded an Innovation Voucher from the Utrecht Holdings. With this money, we will start taking the first steps in upscaling production of our drug, which selectively kills cancer cells.

Accomplished something significant—mastered tying a tie and defended my PhD thesis. My thesis was about how to deliver medicines specifically to cancer cells, and thus minimizing side effects for patients. Because of the promising results in our group, we launched a start-up to minimize side effects of cancer treatment. Interested in how we do that? Follow Lumox, or have a look at the brand new website: www.lumoxbiotech.com Grateful for all the support! ❤️